ClinicalTrials.Veeva

Menu

Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit (REAPHEN)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Patients with Abdominal Infection
Patients with Severe Polytrauma
Patients with Severe Neurological Lesion
Patients Undergoing Esophagectomy

Treatments

Procedure: Lymphocyte Phenotyping Procedure

Study type

Interventional

Funder types

Other

Identifiers

NCT06415474
29BRC23.0109

Details and patient eligibility

About

Patients admitted for polytrauma, severe neurological injury, post-operative monitoring or sepsis/septic shock present with significant inflammation, leading to immunoparalysis, which is responsible for infection, particularly prolonged infection. A study of their lymphocyte phenotype over time could help explore the phenomenon of immunoparalysis.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Postoperative esophagectomy surveillance within the last 24 hours.
  • Patients with intra-abdominal infection
  • Neurological patients with intubation planned for more than 24 hours (subarachnoid hemorrhage with coma, severe head trauma, ischemic or hemorrhagic stroke with coma).
  • Polytrauma with intubation planned for more than 24 hours
  • Patient aged 18 and over
  • Patient with social security coverage

Non-inclusion criteria :

  • Hereditary immune deficiency HIV-AIDS
  • Malignant hemopathies
  • Immunosuppressive treatment other than corticosteroid therapy or chemotherapy
  • Patient under legal protection
  • Pregnant or breast-feeding women

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

80 participants in 1 patient group

Phenotyping arm
Other group
Description:
There is only one arm in the study. All patients (i.e. our 4 target populations) will undergo the same phenotyping procedure.
Treatment:
Procedure: Lymphocyte Phenotyping Procedure

Trial contacts and locations

1

Loading...

Central trial contact

Etienne BOTQUELEN, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems